Triggering of ovulation by a gonadotropin releasing hormone agonist in gonadotropin-stimulated cycles for prevention of ovarian hyperstimulation syndrome and multiple pregnancy

References

• Schenker J. G., Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertil. Steril. 1978; 30: 255–68
   PubMed Web of Science ®Google Scholar
• Schenker J. G., Yarkoni S., Granat M. Multiple pregnancies following induction of ovulation. Fertil. Steril. 1981; 35: 105–23
   PubMed Web of Science ®Google Scholar
• Bettendorf G., Lindner C. The ovarian hyperstimulation syndrome. Honn. Metab. Res. 1987; 19: 519–22
   Google Scholar
• Gelety T. J., Kerin J. F., Surrey E. S. Ovarian hyperstimulation syndrome. Diagnosis and management. Infertil. Reprod. Med. Clin. North Am. 1992; 3: 795–809
   Google Scholar
• Navot D., Bergh P. A., Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and management. Fertil. Steril. 1992; 58: 349–61
   Google Scholar
• Rizk B., Smitz J. Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF and related procedures. Hum. Reprod. 1992; 7: 320–7
   PubMedGoogle Scholar
• Schwartz M., Jewelewicz K. The use of gonadotropins for induction of ovulation. Fertil. Steril. 1981; 35: 3–12
   PubMed Web of Science ®Google Scholar
• Bergh P. A., Navot D. Ovarian hyperstimulation syndrome: a review of pathophysiology. J. In Vitro Fertil. Embryo Trans. 1992; 9: 429–38
   Google Scholar
• Moyle W. R., Bahl O. P., Marz L. Role of carbohydrate of human chorionic gonadotropin in the mechanism of hormone action. J. Bid. Chem. 1975; 25: 963–9
   Google Scholar
• Kosemberg E., Cortés-Prieto J. First demonstration of induction of ovulation with a hybrid human chorionic gonadotropin compound (ABlER-CK-2XY). Fertil. Steril. 1983; 40: 790–7
   Google Scholar
• Balasch J., Gómez F., Casamitjana K., Carmona F., Rivera F., Vanrell J. A. Pituitary-ovarian suppression by the standard and half-doses of D-Trp-6-luteinizing hormone-releasing hormone depot. Hum. Reprod. 1992; 7: 1230–4
   PubMed Web of Science ®Google Scholar
• Gonen Y., Balakier H., Powell W., Casper K. F. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J. Clin. Endocrinol. Metab. 1990; 71: 918–22
   PubMed Web of Science ®Google Scholar
• Imoedemhe D. A. G., Sigue A. B., Pacpaco E. L. A., Olazo A. B. Stimulation of endogenous surge of luteinizing hormone with gonadotropin-releasing hormone analog after ovarian stimulation for in vitro fertilization. Fertil. Steril. 1991; 55: 328–32
   PubMed Web of Science ®Google Scholar
• Itskovitz J., Boldes R., Levron J., Erlik Y., Kahana L., Brandes J. M. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fed. Steril. 1991; 56: 213–20
   PubMed Web of Science ®Google Scholar
• Segal S., Casper R. F. Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization. Fertil. Steril. 1992; 57: 1254–8
   PubMed Web of Science ®Google Scholar
• Lanzone A., Fulghesu A. M., Apa R., Caruso A., Mancuso S. LH surge induction by GnRH agonist at the time of ovulation. Gynecol. Endocrinol. 1989; 3: 213–20
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction, 3rd edn. Cambridge University Press, Cambridge 1992
   Google Scholar
• Rabinovici J., Kushnir O., Shalev J., Goldenberg M., Blankstein J. Rescue of menotrophin cycles prone to develop ovarian hyperstimulation. BY.J. Obstet. Gynaecol. 1987; 94: 1098–102
   PubMedGoogle Scholar
• Belaisch-Allart J., Belaisch J., Hazout A., Testart J., Frydman R. Selective oocyte retrieval: a new approach to ovarian hyperstimulation. Fertil. Steril. 1988; 50: 654–6
   Google Scholar
• Lessing J. B., Amit A., Libal Y., Yovel I., Kogosowski A., Peyser M. R. Avoidance of cancellation of potential hyperstimulation cycles by conversion to in vitro fertilization—embryo transfer. Fertil. Steril. 1991; 56: 75–8
   Google Scholar
• Crosignani P. G., Walters D. E., Soliani A. The ESHFLE multicentre trial on the treatment of unexplained infertility: a preliminary report. Hum. Reprod. 1991; 6: 953–8
   PubMed Web of Science ®Google Scholar
• Karlström P. O., Bergh T., Lundkvist O. A prospective randomized trial of artificial insemination versus intercourse in cycles stimulated with human menopausal gonadotropin or clomiphene citrate. Fertil. Steril. 1993; 59: 554–9
   PubMed Web of Science ®Google Scholar
• Forman R., Fries N., Testart J., Belaisch-Allart J., Hazout A., Frydman R. Evidence for an adverse effect of elevated serum estradiol concentrations on embryo implantation. Fertil. Steril. 1988; 49: 118–22
   PubMed Web of Science ®Google Scholar
• Balasch J., Martinez F., Jové I., Cabré L., Coroleu B., Barri P. N., Vanrell J. A. Inadvertent gonadotrophin-releasing hormone agonist (GnRHa) administration in the luteal phase may improve fecundity in in-vitro fertilization patients. Hum. Reprod. 1993; 8: 1148–51
   PubMed Web of Science ®Google Scholar
• Zelinski-Wooten M. B., Lanzendorf S. E., Wolf D. P., Chandrasekher Y. A., Stouffer R. L. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. 1. Oocyte maturation and corpus luteum function. J. Clin. Endocrinol. Metab. 1991; 73: 577–83
   Google Scholar
• Stone S. C., Schimberni M., Schuster P. A., Werlin L. B., Weathersbee P. Incidence of multiple gestations in the presence of two or more mature follicles in the conception cycle. Fertil. Steril. 1987; 48: 503–4
   Google Scholar